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Qualitative tests for C-reactive protein (CRP) are available for use in dogs, 
and provide a rapid in-house method of detecting acute inflammation. The aim of 
this study was to compare results from a qualitative CRP lateral flow test (Teco 
CRP FASTest) to those obtained from a quantitative CRP ELISA and to tradi-
tional methods of detecting inflammation, including total leukocyte and neutro-
phil numbers, presence of immature neutrophils and a left shift, presence or ab-
sence of toxic changes in neutrophils and plasma fibrinogen concentration in 
whole blood and serum samples collected from 113 client-owned dogs. More 
dogs had CRP FASTest positive results than had quantitatively increased CRP 
(ELISA) or increases in traditional methods used for measuring inflammation. 
Few dogs had increases in markers of inflammation but no elevated CRP. The 
qualitative CRP FASTest was found to be a sensitive test for detecting increased 
CRP concentration and was positive more frequently than were traditional mark-
ers of inflammation.  
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Making an early diagnosis of acute inflammation is important for clini-
cians both in human and veterinary medicine. Detection of non-specific clinical 
signs of inflammation (e.g. fever, inappetence, lethargy) is complemented by 
laboratory methods that have been developed for detecting inflammation. Tradi-
tionally the presence of leukocytosis and neutrophilia, left shifts and toxic 
changes in neutrophils, elevated plasma fibrinogen concentrations and acceler-
ated erythrocyte sedimentation rate have been widely used in veterinary laborato-
ries to assess acute inflammatory processes (Jain, 1986). These traditional meth-
ods have gradually been replaced or supplemented with measurement of acute 
phase proteins (APPs), firstly in human, then in veterinary laboratory medicine 
(Eckersall and Conner, 1988; Kjelgaard-Hansen and Jacobsen, 2011). 
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C-reactive protein (CRP) is considered one of the major positive APPs in 
dogs due to the magnitude of the response in inflammatory processes (Ceron et 
al., 2005; Tecles et al., 2005). Canine CRP has been isolated and characterised 
(Caspi et al., 1984; Yamamoto et al., 1992; Jasensky et al., 2014). It is found 
physiologically in very low serum concentrations in the blood of animals without 
inflammatory disease and a rapid increase in CRP is part of an inflammatory re-
sponse (Ceron et al., 2005), concentration rising as soon as 4 hours after an in-
flammatory stimulus (Caspi et al., 1984). CRP binds directly to dying cells and 
some bacteria, acting as an opsonin, and activates the complement system by the 
classical C1q pathway (Petersen et al., 2004; Jain et al., 2011). 
Unfortunately, quantitative measurement of APP concentrations using an 
ELISA or fluorometric assay is possible only in well-equipped laboratories. A 
relatively new assay, TECOmedical Dog CRP-visual® (Sissach, Switzerland), a 
qualitative canine-specific lateral flow POC assay, showed good agreement with 
a quantitative CRP ELISA method used under laboratory conditions (Plickert et 
al., 2011).  
The aim of this study was to compare the use of the qualitative TE-
COmedical Dog CRP-visual FASTest with the quantitative TECO® Canine CRP 
ELISA, as well as with other more traditional tests used to evaluate inflammation 
(presence of leukocytosis, neutrophilia, left shift and toxic changes in neutro-
phils, and determination of fibrinogen concentration measured by heat precipita-
tion in blood plasma). Left shift and toxic changes were included to help in dis-
tinguishing between stress-induced (mature neutrophilia) and inflammatory leu-
kograms. The qualitative CRP test has not, to the authors’ knowledge, been 
compared to traditional laboratory methods used for detecting inflammation. 
Canine blood samples that were submitted in both EDTA and plain (clot-
ted) tubes to the Clinical Pathology Laboratory of Murdoch University (113 cli-
ent-owned dogs) over a 6-week period underwent a complete blood count as well 
as CRP detection measured using both the Teco CRP point-of-care (POC) lateral 
flow FASTest and the Teco CRP quantitative ELISA. The samples had been col-
lected for diagnostic purposes and animal ethics approval was not required for 
further testing. 
Haematological analysis of each EDTA sample was performed using the 
Siemens Advia 120 haematology system (Bayer, Germany). Leukocytosis was 
recorded if the white cell count exceeded 13.9 × 109/L and neutrophilia if neu-
trophil numbers were > 8.0 × 109/L. Neutrophils were evaluated on a Wright-
Giemsa (Bayer, Germany) stained blood smear for the presence or absence of 
toxic changes (Döhle bodies, cytoplasmic basophilia) and left shift (immature 
neutrophils > 0.3 × 109/L) by a technician and clinical pathologist. 
Fibrinogen concentration was measured in 95 EDTA samples using the 
heat precipitation method (Jain, 1986). The total solids of plasma (TSP) of the 
supernatant from each capillary tube was measured using a temperature-
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calibrated refractometer (Reichert Vet 360, NY, USA) and the TSP from the 
heated tube subtracted from the TSP of the unheated tube to calculate fibrinogen 
concentration. Samples with values > 4 g/L were classified as inflammatory. 
Samples collected in plain (serum) tubes were centrifuged and the serum 
was retained. C-reactive protein was measured in the serum within 2 h of sample 
collection using the qualitative TECO FASTest (Megacor Diagnostik, Germany) 
performed according to the manufacturer’s instructions. The serum samples were 
then frozen at –20 °C and stored until all the samples had been collected (ap-
proximately 2 months). Previous studies have shown that CRP is relatively stable 
even after repeated freeze-thaw cycles (Aziz et al., 2003). CRP was quantified in 
the serum samples using the Teco CRP ELISA® (Teco Medical Group, Switzer-
land) according to the manufacturer’s instructions. Optical density was measured 
at 450 nm using an iMark Microplate Absorbance Reader (BioRad Laboratories, 
USA). The manufacturer suggests that sample values of ≥ 5 mg/L are positive for 
CRP stimulation associated with acute inflammation and samples with > 5 mg/L 
were recorded as inflammatory. 
Data were analysed using Excel® (Microsoft Office Enterprise, 2007, 
USA) to determine median values and standard error, and Spearman’s rank cor-
relation was used to compare results from different tests. Unpaired t-tests were 
used to compare results from the CRP ELISA and traditional markers of inflam-
mation between CRP FASTest positive and negative samples. 
The samples were collected from a variety of canine breeds and cross-
breeds, entire and neutered males and females. The ages of the dogs ranged from 
17 weeks to 14 years. Samples were included from dogs presented for pre-
operative screening and potential blood donors as well as from those with clini-
cally suspected inflammatory diseases. 
Of the 113 samples the lateral flow POC test detected 57 samples positive 
and 56 samples negative for CRP. The samples that were negative with the CRP 
FASTest gave quantitative ELISA CRP values that ranged from 2.05 to 4.64 mg/L, 
apart from one sample that gave an ELISA result of 48.85mg/L. The results are 
summarised in Table 1. 
Table 1 
Range and mean values from all samples tested by CRP FASTest for CRP ELISA and traditional 
markers of inflammation 
 CRP ELISA 
mg/L 
WBC  
(×109/L) 
Neutrophils 
(×109/L) 
Band neutrophils 
(×109/L) 
Fibrinogen  
(g/L) 
Range  2.05–54.8 2.6–84.0 0.6–44.9 0–17.6 0–6 
Mean of negatives 3.9 10.1 7.2 0.19 2 
Mean of positives 30.5 15.3 12.4 1.7 3 
Characterisation in positives and negatives based on the CRP FASTest 
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There was a significant increase (P < 0.001) in CRP concentration meas-
ured by ELISA, total leukocyte count, neutrophil numbers and left shift, toxic 
changes and fibrinogen concentration in CRP FASTest positive samples com-
pared to those that were CRP FASTest negative (Fig. 1). 
 
 
 
Fig. 1. Histograms comparing the mean ± standard error (SE) of quantitative CRP concentration, 
total leukocyte count, neutrophil count, neutrophil left shift, presence of toxic changes and fibrino-
gen concentration between samples which tested negative versus those that tested positive for CRP 
using the CRP FASTest 
 
There was good correlation between the CRP ELISA and FASTest (r = 
0.83) but only moderate to poor correlation between the CRP FASTest and total 
leukocyte count (r = 0.43), total neutrophil count (r = 0.38), immature neutrophil 
numbers (r = 0.33), fibrinogen concentration (r = 0.47) and presence or absence 
of toxic changes (r = 0.34). 
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Six of the samples with high total leukocyte counts (15.7–84.0 × 109/L) 
gave negative test results using both the CRP lateral flow FASTest and CRP 
ELISA. The clinical history showed that all 6 dogs were receiving immunosup-
pressive therapy. 
The CRP FASTest appears to be a reliable screening test for CRP as all 
the samples with quantitative ELISA CRP concentrations higher than 5 mg/L 
gave positive CRP FASTest results. This supports the conclusions of another 
study (Plickert et al., 2011). The CRP FASTest was positive in 9 samples (8%) 
with negative CRP ELISA results. This may be due to the higher sensitivity of 
the FASTest or increased false positives detected by the CRP FASTest. 
The CRP FASTest was more frequently positive in dogs with quantita-
tively increased CRP concentration than other commonly used laboratory meth-
ods used for detecting inflammation including leukocytosis, neutrophilia, left 
shift, toxic changes and plasma fibrinogen concentration; however, these pa-
rameters were significantly increased in the CRP FASTest positive group com-
pared to the CRP FASTest negative group. The increases in traditional makers of 
inflammation with negative CRP FASTest results may be due to a more chronic 
inflammatory process, and acute phase proteins may therefore already have de-
creased. Further investigations looking at leukocyte count and morphology over 
time would be of value. 
A shortcoming of our study is that only limited numbers of samples from 
animals treated with immunosuppressant drugs were tested. Previous studies 
have suggested that corticosteroids may not influence CRP concentration in 
healthy dogs (Martinez-Subiela et al., 2004) and may lower CRP concentration 
in dogs with sepsis (Caldin et al., 2009). Other explanations for a low CRP con-
centration with leukocytosis may include chronic inflammation where the CRP 
has already decreased, or a physiological leukocytosis without inflammation. 
Other limitations of this study included the lack of follow-up samples to 
compare progression of inflammatory changes compared to CRP concentration. 
Sampling to follow the progression of disease would help to determine whether 
traditional indicators of inflammation occurred after CRP concentration in-
creased, or vice versa. An advantage of a qualitative CRP test over a quantitative 
ELISA test is the production of a rapid result and easy means of testing. A major 
disadvantage of this simple-to-do CRP FASTest is that it only indicates the pres-
ence or absence of elevated CRP. Therefore this test cannot be used to evaluate 
the progression of disease or variations in inflammatory response. 
In conclusion, the CRP FASTest® is a quick, easy-to-use test that is sensi-
tive for detection of elevated CRP and can be performed on individual canine 
blood samples in a practice setting. It is more sensitive at detecting increased 
CRP than more traditional markers of inflammation. 
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